Three studies advance blood tests for detecting CTE in living people
washu.edu

Three studies advance blood tests for detecting CTE in living people

The gist

Three separate research teams reported blood-based markers that may help identify CTE, a brain disease now confirmed only at autopsy.
A living-patient test would open the door to clinical trials and earlier diagnosis.

How it unfolded

  1. Nov 13, 2026A Washington University School of Medicine in St. Louis study in JAMA found the Alzheimer's blood biomarker eMTBR-tau243 is also elevated in advanced CTE, testing blood from 11 people whose CTE was confirmed at autopsy among 229 participants.
  2. Nov 13, 2026The same study found the test distinguished advanced CTE from healthy people with high accuracy but could not reliably identify early-stage CTE; levels in CTE were much lower than in Alzheimer's disease.
  3. Nov 18, 2026A Mass General Brigham, Boston University and Concussion & CTE Foundation review in JAMA Network Open of 12 studies covering 4,421 deceased individuals found CTE pathology in 29, or 0.66%.

Key terms

CTE
A neurodegenerative brain disease caused by repeated head trauma, leading to mood, behavior, and thinking problems that worsen over time.
biomarker
A measurable biological indicator of a body's state or condition, often tested in blood, urine, or tissue.
autopsy
A surgical examination of a corpse by dissection to determine the cause, mode, and manner of death.

Source: Wikipedia

Sources

Read the full story in the app Gistline — free on the App Store